JPRN-UMIN000017219招募中未知
Feasibility and efficacy of the de-escalation therapy by Biapenem for postoperative bacterial pneumonia. - Feasibility and efficacy of the de-escalation therapy by Biapenem for postoperative bacterial pneumonia.
Department of Gastrointestinal Surgery, The University of Tokyo Hospital0 个研究点目标入组 20 人开始时间: 2015年4月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Other infectious disease including SSI is present. History of hyper reactive events caused by carbapenem. The suspected pathogenic microbes of the pneumonia is; MRSA, MDRP, virus, mycoplasma, regionera, clmamigia, MAC, yeast. MRSA or MDRP is present in any culture specimen during the in hospital course. History of epilepsy or barproic acid use. Renal disease with Ccr lower than 20ml/kg.min or requiring hemodialysis.
研究者
相似试验
招募中
4 期
RA-BE-LEAVE studyRheumatoid arthritisJPRN-jRCTs051220168Miyazaki Yusuke210
进行中（未招募）
2 期
A phase 2 study of neoadjuvant Pembrolizumab in cutaneous squamous cell carcinoma (cSCC).Head and Neck CancerCutaneous Squamous Cell CancerCancer - Head and neckCancerACTRN12621000901808Metro South Hospital and Health Services47
已完成
2 期
De-escalation and stopping treatment of imatinib, nilotinib or sprycel in chronic myeloid leukaemiaTopic: National Cancer Research NetworkSubtopic: Haematological OncologyDisease: Leukaemia (chronic)Chronic myelogenous leukaemiaCancerISRCTN74084226niversity of Liverpool (UK)168
进行中（未招募）
1 期
A trial of de-escalation and stopping treatment in chronic myeloid leukaemia patients with excellent responses to tyrosine kinase inhibitor therapy DESTINY (De- Escalation and Stopping Treatment of Imatinib, Nilotinib or sprYcel in chronic myeloid leukaemia)Chronic myeloid leukaemiaMedDRA version: 16.0 Level: LLT Classification code 10009015 Term: Chronic myeloid leukemia System Organ Class: 100000004864MedDRA version: 16.0 Level: LLT Classification code 10009016 Term: Chronic myeloid leukemia in remission System Organ Class: 100000004864EUCTR2012-004025-24-GBniversity of Liverpool174
尚未招募
不适用
Distance- Based Physical Activity Intervention for Rural Lung Cancer Survivors.ung CancerCancer - Lung - Non small cellCancer - Lung - Small cellLung CancerACTRN12612000085875Edith Cowan University50